Ascendis Pharma A/S

Status: Publicly traded

Direct answer

Ascendis Pharma A/S is publicly traded on NASDAQ under the ticker ASND.

Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing therapeutic solutions for critical medical conditions that currently lack effective treatments. Its commercialized offering is SKYTROFA, a therapy prescribed for individuals suffering from growth hormone deficiency (GHD). The company boasts a robust development pipeline, featuring several TransCon-branded candidates. These include TransCon...

Can you invest in Ascendis Pharma A/S?

Yes. Ascendis Pharma A/S trades publicly on NASDAQ as ASND.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Ascendis Pharma A/S

Detailed equity research is provided by MarketSnap.